Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT.
Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC.
Am Heart J. 2022 Aug;250:11-22. doi: 10.1016/j.ahj.2022.04.009. Epub 2022 May 5.
To compare rates of severe maternal morbidity (SMM) for pregnant patients with a cardiac diagnosis classified by the modified World Health Organization (mWHO) classification to those without a cardiac diagnosis.
This retrospective study using the 2015-2019 Nationwide Readmissions Database identified hospitalizations, comorbidities, and outcomes using diagnosis and procedure codes. The primary exposure was cardiac diagnosis, classified into low-risk (mWHO class I and II) and moderate-to-high-risk (mWHO class II/III, III, or IV). The primary outcome was SMM or death during the delivery hospitalization; secondary outcomes included cardiac-specific SMM during delivery hospitalizations and readmissions after the delivery hospitalization.
A weighted national estimate of 14,995,122 delivery admissions was identified, including 46,541 (0.31%) with mWHO I-II diagnoses and 37,330 (0.25%) with mWHO II/III-IV diagnoses. Patients with mWHO II/III-IV diagnoses experienced SMM at the highest rates (22.8% vs 1.6% for no diagnosis; with adjusted relative risk (aRR) of 5.67 [95% CI: 5.36-6.00]). The risk of death was also highest for patients with mWHO II/III-IV diagnoses (0.3% vs <0.1% for no diagnosis; aRR 18.07 [95% CI: 12.25-26.66]). Elevated risk of SMM and death persisted to 11 months postpartum for those patients with mWHO II/III-IV diagnoses.
In this nationwide database, SMM is highest among individuals with moderate-to-severe cardiac disease based on mWHO classification. This risk persists in the year postpartum. These results can be used to enhance pregnancy counseling.
比较患有经改良世界卫生组织(mWHO)分类的心脏诊断的孕妇与无心脏诊断的孕妇严重产妇发病率(SMM)的发生率。
本回顾性研究使用 2015 年至 2019 年全国再入院数据库,使用诊断和程序代码确定住院、合并症和结局。主要暴露因素为心脏诊断,分为低危(mWHO I 类和 II 类)和中高危(mWHO II/III 类、III 类或 IV 类)。主要结局为分娩住院期间发生 SMM 或死亡;次要结局包括分娩住院期间心脏特异性 SMM 和分娩后住院再入院。
确定了全国 14995122 例分娩入院的加权估计值,其中 46541 例(0.31%)有 mWHO I-II 诊断,37330 例(0.25%)有 mWHO II/III-IV 诊断。mWHO II/III-IV 诊断患者 SMM 发生率最高(22.8% vs 无诊断 1.6%;调整后相对风险(aRR)为 5.67 [95%CI:5.36-6.00])。mWHO II/III-IV 诊断患者死亡风险也最高(0.3% vs 无诊断 <0.1%;aRR 18.07 [95%CI:12.25-26.66])。mWHO II/III-IV 诊断患者的 SMM 和死亡风险在产后 11 个月仍居高不下。
在这项全国性数据库中,根据 mWHO 分类,中度至重度心脏疾病患者的 SMM 发生率最高。这种风险在产后一年仍持续存在。这些结果可用于加强妊娠咨询。